Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

A Declaration of Openness in Using Animals in Research

Published: Monday, October 22, 2012
Last Updated: Monday, October 22, 2012
Bookmark and Share
The MRC and other members of the research sector have signed a declaration on transparency in animal research.

The declaration, which is being signed by universities, funders and charities, is the first step in producing a concordat which will set out principles of open communication, as well as some practical steps and measurable objectives for a more transparent approach across the bioscience community.
 
The declaration was in response to the latest MORI poll commissioned by the Department for Business, Innovation and Skills which showed a slight drop in the public acceptance of animal research. Whilst the majority of people still support the need for animals to be used in medical research where there is no alternative, the figures also show that a significant proportion of the population want to know more about the reasons why animals are used and the strict conditions under which that use is regulated.
 
The poll also indicated a fall in trust in the regulation of animal experimentation in the UK. 43% expect that the rules in Britain on animal experimentation are well enforced, down from 56% in 2010.
 
At a press briefing to launch the declaration and the poll, David Willetts, Minister for Universities and Science, discussed how life sciences using animal research not only brought about significant advances in the treatment of disease but was also of great economic importance in the UK. Mr Willetts also spoke of the Government’s support (via the MRC and BBSRC) for The National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), an independent organisation that supports the UK science base to replace, refine and reduce the use of animals in research and which funds research into replacing, refining and reducing the use of animals in research.
 
Stephen Whitehead, Chief Executive of the Association of the British Pharmaceutical Industry, stated that the signing of this Declaration “marked a ‘sea change’ in the life sciences community. We are now in a position where we can take a more forthright approach about the necessity of our research. We will not be afraid to admit that we will continue to carry out research in this way until viable alternatives are found.”
 
Professor Sir John Savill, Chief Executive of the Medical Research Council, said “People choose to work in medical research because they want to find cures and treatments for disease. Sometimes their research will involve the use of animals but it’s not a quick, cheap or easy option; animals are used when they’re the only option. Fortunately, UK research animals have never been better cared for and their use has never been more strictly regulated. We’re constantly looking at ways to reduce the number of animals used and to replace them with alternatives but, right now, their use is still necessary.
 
“The MRC has a long-held policy of being transparent about animal use and we believe we have a duty to be open to the taxpayers whose money we spend. We’re not just open, we’re proud of that research. This year alone, MRC-funded researchers have used mice to look at a mechanism which may hold the key to why brain cells die and cause dementia; transplanted stem cells into gerbils to cure deafness; and have successfully used adult human retinal stem cells to partially restore vision in rats, a crucial step in bringing forward a cure for some forms of blindness and giving hope to many patients.
 
“It's hard to think of any treatment or drug therapy available today that has not relied on the use of animals at some point in its development and, where there is no viable alternative, we will continue to use animals in research to improve people’s lives.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Liver Regrown from Stem Cells
Scientists have repaired a damaged liver in a mouse by transplanting stem cells grown in the laboratory.
Wednesday, July 22, 2015
MRC, GSK and Five Leading UK Universities Collaborate
Collaboration to crack difficult disease areas.
Thursday, July 16, 2015
‘Mini Bile Ducts’ used to Discover New Drugs that could Prevent Liver Damage
An experimental cystic fibrosis drug has been shown to prevent the disease’s damage to the liver, thanks to a world-first where scientists grew mini bile ducts in the lab.
Tuesday, July 14, 2015
First RNAi Meiosis Screen Reveals Genes Essential to Generate Eggs
Screening techniques developed leading to the discovery of genes essential for meiosis in mammals.
Wednesday, July 08, 2015
Study Identifies New Way to Kill the Malaria Parasite
Scientists have discovered new ways in which the malaria parasite survives in the blood stream of its victims, a discovery that could pave the way to new treatments for the disease.
Tuesday, July 07, 2015
Making Vaccines More Effective In The Elderly
Compound shown to restore the immune system’s inbuilt memory.
Tuesday, November 11, 2014
Immune Organ Regenerated in Mice
Scientists have for the first time used regenerative medicine to fully restore a degenerated organ in a living animal.
Tuesday, April 08, 2014
AstraZeneca, MRC Collaboration to Create New Centre for Early Drug Discovery
The Companies today announced the groundbreaking collaboration aimed at better understanding the mechanisms of human disease. The collaboration will see the creation of a joint research facility at AstraZeneca’s new R&D centre in Cambridge in the UK.
Monday, March 31, 2014
MRC Invests £32M to Improve Data Research
Investment will improve capability, capacity and capital infrastructure in medical bioinformatics.
Friday, February 07, 2014
Redirecting the Rules of Attraction in Fruit Flies
MRC researchers have discovered a biological switch that determines which part of the fruit fly’s brain responds to pheromones, depending on whether the fruit fly is male or female.
Friday, December 20, 2013
A Gene Mutation for Excessive Alcohol Drinking Found
UK researchers have discovered a gene that regulates alcohol consumption and when faulty can cause excessive drinking.
Wednesday, November 27, 2013
MRC Laboratory of Molecular Biology Alumni Awarded Nobel Prize for Chemistry
Professor Michael Levitt, Professor Arieh Warshel and Professor Martin Karplus awarded the 2013 Nobel Prize in Chemistry.
Monday, October 14, 2013
Study Leads to Alzheimer's Breakthrough
Researchers at the Medical Research Council Toxicology Unit have used an orally-administered compound to block a major pathway leading to brain cell death in mice, preventing neurodegeneration.
Thursday, October 10, 2013
£25m to Kick-Start ‘Industrial Revolution’ in Regenerative Medicine
Applications will include Parkinson’s disease, cardiovascular disease, wound and musculoskeletal repair, eye disorders and deafness.
Wednesday, September 11, 2013
3D Tissue Grown from Stem Cells - New Model System for Brain Development
An international team of researchers has used stem cells to create a 3D structure that mimics early human brain development.
Monday, September 02, 2013
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!